Specialty pharmacies are under growing financial pressure due to high drug costs, delayed reimbursements, and limited access to support programs like 340B. This cash-flow strain threatens patient access—especially in underserved areas—as some pharmacies are forced to close or exit the market. Addressing the crisis requires faster payments, expanded program access, and reform of pharmacy benefit manager practices to ensure the sustainability of specialty care.